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Background: The non-long terminal repeat (non-LTR) retrotransposons, long interspersed element-1 (LINE-1) and
Alu are currently active retroelements in humans. We, and others, have observed that different populations of HeLa
cells from different laboratories support retrotransposition of LINE-1 and Alu to varying degrees. We therefore
tested whether individual cell clones of HeLa and HCT116 cell lines supported different levels of LINE-1 and Alu
retrotransposition, and whether these variations were stable upon re-cloning.
Findings: Standard retrotransposition tissue culture assays were used to measure a cell’s ability to support LINE-1
and Alu retrotransposition in clonal HeLa and HCT116 cell lines. We observed that both LINE-1 and Alu
retrotransposition exhibited clonal variation in HeLa cells, with certain HeLa cell clones supporting high levels of
LINE-1 and Alu retrotransposition and other cell clones being essentially retrotransposition-dead. This clonal
variation was similarly observed in HCT116 cells, although possibly not to the same extent. These patterns of clonal
variation are relatively consistent upon re-cloning.
Conclusions: Observations of the variability of LINE-1 and Alu retrotransposition in different populations of the
same cell line are supported by our results that indicate in some cell types, individual cell clones can have
dramatically differing capacity for retrotransposition. The mixed populations of cells commonly used in laboratories
have often been passaged for many generations and accumulated significant genetic and epigenetic diversity. Our
results suggest that the clonal variability observed by our cloning experiments may lead to a homogenization of
retrotransposition capacity, with the resulting mixed population of cells being composed of individual variants
having either increased or decreased retrotransposition potential compared to the starting population.
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Introduction
Long interspersed element-1 (LINE-1) and Alu retro-
transposons make up nearly one half of the DNA content
of the human genome [1]. Mobilization of autonomous
LINE-1 and non-autonomous Alu elements is currently
ongoing in human genomes and has been implicated in a
number of genetic diseases [2-4]. In order to study
mobilization of LINE-1 and Alu, plasmid-based reporter
systems have been widely used [5]. Retrotransposition
rates appear to vary widely between different cell types, but
it has also been observed that different populations of the* Correspondence: pdeinin@tulane.edu
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reproduction in any medium, provided the orsame cell type support LINE-1 and Alu retrotransposition
to varying degrees [6]. Additionally, we have observed
fluctuation in the retrotransposition potential of cell lines
as they are grown in our laboratory over time and others
have observed differential effects on LINE-1 and Alu
within variations of HeLa [6]. We wished to determine
whether this variation was at least partially due to genetic
variation and evolution of cells in culture. These observa-
tions led us to compare the potential for LINE-1 and Alu
retrotransposition of clones of two commonly used cell
lines, HeLa and HCT116.
Methods
HeLa and HCT116 cells were obtained from ATCC
(Manassas, VA, USA). HeLa and HCT116 cells were
maintained in minimum essential medium (MEM)
(Invitrogen, Carlsbad, CA, USA) supplemented with 10%td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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amino acids and sodium pyruvate (Invitrogen). HeLa and
HCT116 cell lines were cloned by limiting dilution in a
96-well plate format and multiple clones were tested for
LINE-1 and Alu retrotransposition using previously de-
scribed reporter assays [5].
Briefly, one million cells were seeded per 75 cm2 flask.
One day after seeding, cells were transfected using
Lipofectamine (Invitrogen) according to the manufac-
turer’s protocol, with either 1 μg JM101/L1.3 [5] for
LINE-1 retrotransposition assays or 1 μg AluYa5-neoTET
[7] and 1 μg JM101/L1.3-no tag [8] (an untagged expres-
sion cassette for L1.3, provided by JV Moran) as a driver
for Alu retrotransposition assays. The plasmids, upon in-
tegration, reverse transcription and retrotransposition,
yield cells resistant to the antibiotic G418, allowing meas-
urement of the rate of LINE-1 and Alu retrotransposition.
In parallel, to control for transfection efficiency, which
can vary between cell clones and between experiments,
clones were transfected with 300 ng of pIRES (Addgene,
Cambridge, MA, USA), a plasmid that confers G418 re-
sistance to the transfected cells.
Twenty-four hours after transfection, media containing
G418 was added to select for integration events. G418 se-
lection was maintained for 10 to 14 days until visible col-
ony formation. Colonies were stained with 5% (w/v) crystal
violet solution and counted using an automated cell coun-
ter (ColCount, Oxford Optronix, Abingdon, UK). Retro-
transposition colony counts were normalized to pIRES
colonies for each experiment to correct for differences in
transfection efficiency. For each independent experiment,
the clone with the highest transfection efficiency, as deter-
mined by pIRES colony number, was set as 100% and each
other clone was adjusted by the percentage that that clone
differed from the clone with the highest transfection effi-
ciency for that experiment. The mean number of pIRES
colonies across all experiments was 1,050 (SD = 332). Data
are presented for LINE-1 and Alu retrotransposition. Stat-
istical significance was performed using GraphPad Prism
software (La Jolla, CA, USA) and one-way ANOVA with
Tukey’s post-test to compare means.
Results
Because many cancer cell lines have relatively unstable
genomes, we hypothesized that their genome variation
could lead to altered abilities to support retrotransposition.
To determine whether there was clonal variability in the
potential for HeLa clones to support LINE-1 retrotrans-
position, we performed LINE-1 retrotransposition assays
using eight individual HeLa cell clones and the parental
population of HeLa from which they originated. The re-
sults of the LINE-1 retrotransposition assays in HeLa
clones confirm that some cell clones are nearly incapable
of supporting LINE-1 retrotransposition (HeLa clone 1),while other cell clones are particularly amenable to
LINE-1 retrotransposition events (HeLa clone 7). LINE-1
retrotransposition rates in HeLa clone 7 (mean = 699 col-
onies) were significantly increased compared to those in
HeLa clone 1 (mean = 5 colonies) (Figure 1A). Both HeLa
clone 1 and HeLa clone 7 differ significantly from the par-
ental HeLa population in their ability to undergo LINE-1
retrotransposition, with the parental population showing a
level of LINE-1 retrotransposition intermediate between
the two clones (Figure 1A). Representative flask images for
HeLa clones are shown in Additional file 1: Figure S1A,B.
To test if the large discrepancy in LINE-1 retrotrans-
position potential between HeLa clones 1 and 7 was
paralleled for Alu retrotransposition, we performed Alu
retrotransposition assays in the same HeLa clones. As was
the case with LINE-1 retrotransposition, the ability of
HeLa clone 7 to retrotranspose Alu (mean = 503 colonies)
was significantly elevated (252-fold) compared to the ability
of HeLa clone 1 to support Alu retrotransposition (mean =
1 colony). Additionally, remaining HeLa subclones were
fairly consistent in their ability to retrotranspose Alu,
showing fairly modest rates of retrotransposition. None of
the individual HeLa clones supported Alu retrotrans-
position as well as the parental population, suggesting that
there was even more heterogeneity that was not sampled
in this study (Figure 1B).
To test if the observed clonal effect on LINE-1 and Alu
retrotransposition was specific to HeLa cells, we tested
LINE-1 and Alu retrotransposition in clones of HCT116
cells, as above. Unlike HeLa clones, HCT116 clones did
not exhibit any significant variation in either LINE-1 or
Alu retrotransposition rates in any of the tested clones
(Figure 1C,D). Additionally, the parental population of
HCT116 cells showed similar levels of retrotransposition
to each of the clones (Figure 1C,D). This is in contrast to
our HeLa data, which showed a 140-fold and 503-fold dif-
ference between retrotransposition permissive and non-
retrotransposition permissive clones for LINE-1 and Alu,
respectively (Figure 1A,B). Representative flask images for
HCT116 clones are shown in Additional file 1: Figure
S1C,D.
We next wanted to determine if the observed differences
in LINE-1 and Alu retrotransposition in clones of HeLa
when compared to HCT116 clones was stable upon
subcloning. This scenario is an experimental mimic to
what might occur during tissue culture passaging if any
one cell outgrows the others to become the predominant
component of the cell mixture. To this end, we re-cloned
two of the original HeLa clones that showed varying de-
grees of support for retrotransposition of LINE-1 and Alu
(clones 1 and 7) to obtain HeLa subclones 1A, 1B, 1C, 1D
and 7A, 7B, 7C and 7D. We also subcloned two HCT116
clones (clones 5 and 6) to obtain HCT116 subclones 5A,
5B, 5C and 6A, 6B and 6C. We then performed the same
Figure 1 LINE-1 and Alu exhibit clonal variation. (A) LINE-1 retrotransposition assays were performed in eight individual HeLa cell clones and
parental HeLa population. Different HeLa clones exhibit different potential for LINE-1 retrotransposition, with HeLa clone 1 exhibiting a 140-fold
reduction in LINE-1 retrotransposition rate compared to HeLa clone 7. (B) Alu retrotransposition assays were performed in HeLa cell clones and
parental HeLa. Differences in Alu retrotransposition between the two HeLa clones were even greater than those observed for LINE-1, with a 252-
fold reduction in Alu retrotransposition in HeLa clone 1 compared to HeLa clone 7. (C) LINE-1 retrotransposition assays were also preformed in
HCT116 cell clones to examine whether the effect seen in HeLa also occurred in HCT116 cells. The LINE-1 retrotransposition clonal variation was
not observed in five HCT116 cell clones. (D) Alu retrotransposition assays were tested in seven HCT116 cell clones and parental HCT116 cell
population and no significant differences in rates of Alu retrotransposition were observed between HCT116 clones. Error bars represent SEM.
Sample size is four independent experiments (independent transfections) each performed in triplicate (n = 12). Asterisks indicate statistical
significance from the parental population of at least P <0.05 by one-way ANOVA with Tukey’s post-test. LINE-1, long interspersed element-1; SEM,
standard error of the mean.
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HCT116 subclones and the parental populations of cells.
The LINE-1 retrotransposition differences seen in the re-
cloned HeLa clones (1A, 1B, 1C, 1D and 7A, 7B, 7C and
7D) was consistent with the observed difference in
these two clones prior to re-cloning (compare Figure 2A
to Figure 1A) in that the subclones of HeLa clone 1 all
remained essentially incapable of undergoing retrotrans-
position. It is interesting to note, however, that we
observed variability in the rates of retrotransposition in the
subclones of HeLa clone 7, with two of the subclones
(HeLa subclones 7A and 7B) displaying significantly re-
duced rates of LINE-1 retrotransposition when compared
to two others (HeLa subclones 7C and 7D) (Figure 2A).
Similarly in HCT116 clones 5A, 5B, 5C and 6A, 6B and
6C, there was no statistically significant observed differencein the rates of LINE-1 retrotransposition between clones
(Figure 2B), which is in agreement with the data from these
cells before being re-cloned (Figure 1B). Taken together,
these data imply that the observed clonal differences in
ability to support retrotransposition are stable to varying
extents and are propagated as cells are passaged.
Discussion
Our data demonstrate that differences in the rates of
LINE-1 and Alu retrotransposition between different pop-
ulations of the same cell type may be the result of clonal
variation in retrotransposition potential being accumulated
over time. While no noticeable differences were observed
in growth rate or morphology between clones, it is possible
that this clonal variation is the result of genetic differences










































LINE-1 Retrotransposition in subcloned HeLa Clones
Figure 2 Differences in LINE-1 retrotransposition between cell clones are maintained upon cell subcloning. (A) HeLa clones 1 and 7 were
re-cloned and LINE-1 retrotransposition assays were performed. The differences in LINE-1 retrotransposition potential were maintained between
HeLa subclones, with the four HeLa clone 1 subclones exhibiting a large reduction in LINE-1 retrotransposition rates compared to the four HeLa
clone 7 subclones. (B) HCT116 clones 5 and 6 were re-cloned and LINE-1 retrotransposition assays were performed. As with the original HCT116
cell clones, there were no significant differences in LINE-1 retrotransposition rates between HCT116 subclones. Error bars represent SEM. Sample
size is four independent experiments (independent transfections) each performed in triplicate (n = 12). Asterisks indicate statistical significance
from the parental population of at least P <0.05 by one-way ANOVA with Tukey’s post-test. LINE-1, long interspersed element-1; SEM, standard
error of the mean.
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tially more reversible epigenetic change. However, the im-
plications of variations in retrotransposition competency
between clones of the same cell type are important to con-
sider in many experimental designs. n a mixed population
of cells, any one individual cell has the potential to outgrow
other cells in tissue culture. If this is the case, this individ-
ual cell’s ability to support retrotransposition predominates
in the mixed population of cells. This can result in a
population of cells becoming either increasingly supportive
of retrotransposition or losing the ability to support
retrotransposition altogether. In addition, if an experimen-
tal protocol involves cell cloning, as is often the case when
using shRNA and other genetic transformations, one must
consider the arbitrary nature of this potential cloning vari-
ation. Thus, it may be worth characterizing multiple cell
clones, or alternatively subcloning a cell line prior to such
studies in order to begin with a more homogeneous cell
population.
It seems obvious that due to their potential to cause mu-
tagenic (reviewed in [3,4,9]) and toxic [4,10] effects on
cells, organisms have developed a remarkably wide array ofdefenses against mobile elements. These have included a
number of factors that suppress transcription (reviewed in
[11]), as well as influences thought to be at the level of the
RNA [11-13] or even the integration process [14,15]. Thus,
because so many factors control retrotransposition, there
are many genetic variations that can occur to cells that
may alter the process. Our data show that simply culturing
cells over long periods of time result in variations in factors
that influence retrotransposition. This may have particular
relevance to cancer where cells generate genetic diversity
rapidly and new clonal variants arise during tumor pro-
gression. This clonal variation may be one of the reasons
why there is so much variation in L1 activity between dif-
ferent types of cancer, as well as between different cancers
of the same type [16,17].Additional file
Additional file 1: Representative flask images of HeLa and HCT116
clones. (A) Alu and LINE-1 retrotransposition and pIRES colony formation
in HeLa clone 7. (B) Alu and LINE-1 retrotransposition and pIRES colony
formation in HeLa clone 1. (C) Alu and LINE-1 retrotransposition and
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retrotransposition and pIRES colony formation in HCT116 clone 3.
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